cmAngio® vs Zio AT ECG Monitoring System
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your primary goal is to leverage existing mammography data for early cardiovascular risk assessment in women. This tool is ideal for integrating a non-invasive method to identify Breast Arterial Calcifications (BAC) during routine breast cancer screenings, providing valuable insights into potential cardiovascular health concerns without additional procedures or radiation.
View cmAngio® →Choose Zio AT ECG Monitoring System if…
Choose Zio AT ECG Monitoring System if you need continuous, long-term ECG monitoring for comprehensive arrhythmia detection in patients. This wearable solution is best suited for identifying both symptomatic and asymptomatic cardiac events over an extended period, providing clinicians with detailed reports for diagnosing and managing various heart rhythm disorders.
View Zio AT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | Zio AT ECG Monitoring System |
|---|---|---|
| Pricing | Paid, out-of-pocket | Contact for pricing |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | Cloud-based (data analytics and clinician portal) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cmAngio®cmAngiou00ae (Tool A) offers quick and easy installation, integrating seamlessly into existing radiology workflows and being compatible with any DICOM-compliant viewer. This minimizes disruption and training for clinical staff. In contrast, the Zio AT system (Tool B) involves a multi-component system with a wearable patch, wireless gateway, and separate clinician and patient mobile apps, which, despite efforts for patient ease, introduces more elements for users to manage.
Clinical Value
Zio AT ECG Monitoring SystemThe Zio AT ECG Monitoring System (Tool B) provides direct, continuous, and highly accurate diagnostic and monitoring capabilities for cardiac arrhythmias, demonstrably impacting patient management and reducing hospital admissions. cmAngiou00ae (Tool A) offers significant value by repurposing existing mammography data for cardiovascular risk assessment, identifying an often-underreported finding. However, Tool B's direct diagnostic and management impact on a specific, critical cardiac condition gives it a slight edge in immediate clinical utility.
Pricing & Value
Zio AT ECG Monitoring SystemBoth tools lack transparent public pricing, requiring direct contact with the vendor. However, iRhythm (Tool B) provides more detailed information on its billing models, including a 'Direct Bill program' to insurance and various patient assistance programs to minimize out-of-pocket costs. Studies also suggest the Zio service has a low cost per diagnosis due to its high diagnostic yield, offering a clearer value proposition despite opaque pricing.
Enterprise Readiness
Zio AT ECG Monitoring SystemBoth tools are FDA-cleared, HIPAA-compliant, and cloud-based, indicating a strong foundation for enterprise adoption. However, the Zio AT system (Tool B) explicitly confirms the availability of a Business Associate Agreement (BAA) in its structured facts. Tool A (cmAngiou00ae) requires contacting the vendor for BAA details, making Tool B slightly more transparent regarding this critical enterprise compliance requirement.
Innovation
Zio AT ECG Monitoring SystemThe Zio AT system (Tool B) represents a comprehensive innovation in continuous cardiac monitoring, combining a wearable patch, wireless data transmission, and a deep-learned AI algorithm for superior arrhythmia detection and patient outcomes. cmAngiou00ae (Tool A) is innovative in its ability to extract new, clinically relevant cardiovascular risk insights from existing mammography data, creating a 'two-for-one' screening opportunity. However, Tool B's integrated, end-to-end system for active, long-term monitoring demonstrates a broader and more advanced approach to patient care delivery.
Support & Docs
Zio AT ECG Monitoring SystemThe Zio AT system (Tool B) offers a robust support ecosystem, including dedicated clinician and patient mobile apps for management and education, comprehensive FAQs, detailed instructions for use, and 24/7 customer care with patient advocates. In contrast, cmAngiou00ae (Tool A) provides minimal explicit details on its support and documentation resources in the provided information or public web searches.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | Zio AT ECG Monitoring System |
|---|---|---|
| Product Name | cmAngiou00ae | Zio AT ECG Monitoring System |
| Company | CureMetrix | iRhythm Technologies, Inc. |
| Description | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. | FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting. |
| Primary Clinical Focus | Breast Arterial Calcifications (BAC) detection on mammograms for cardiovascular risk assessment | Long-term arrhythmia detection via continuous ECG monitoring |
| Key Feature 1 | AI-based detection of Breast Arterial Calcifications (BAC) | Wearable Zio AT patch for continuous ECG recording |
| Key Feature 2 | Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams | Wireless gateway for real-time data transmission |
| Key Feature 3 | Provides visualization of BAC location on a scorecard | FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and Zio AT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring cmAngio® or Zio AT ECG Monitoring System
Backers
Who funded each tool's parent company.